Conference
Open access
Sep 2026
LMNA-NTRK1 fusion–positive MSI-high colorectal cancer responding to FOLFOX plus bevacizumab after immune checkpoint inhibitor failure: a case report
K. Sawada, Ryosuke Watanabe, Kohei Okamoto et al.
· International Cancer Confere... · 0 citations